The Animal Model Core (AMC) provides relevant experimental tools and animal models that would support and enhance the research approaches of CURE: DDRCC member in irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), obesity and Parkinson diseases-related Gl dysmotility using mice as a prominent experimental model.-This is achieved through the following services i. Education and training of members on methods, protocols, best practice of animal use, and preparation of animal experimental protocols for institutional approval; ii. Access to well characterized relevant chemical genetic or experimental models of stress, IBS, colitis, visceral obesity and Parkinson disease-related constipation in rats or mice; iii Access to state-of-the art equipment use and training for functional bioassays to assess gastrointestinal propulsive motor function, visceral pain, intestinal permeability and inflammation, food intake microstructure, body composition, energy homeostasis and brain-gut interaction in mice or rats. iv. Performance of drug delivery, collection of body fluid and surgical procedures; v. Access to genetically modified mice via institutional shared resources. The vast array of animal models and methodological approaches offered is made possible through the complementary and well established expertise of the AMC Directors and Personnel in the fields of stress, brain-gut interactions, gut motility, visceral pain, intestinal inflammation and feeding behavior. In particular expertise of AMC Directors lead to substantial methodological advances namely the developed novel noninvasive monitoring of gut motility and visceral pain in conscious mice and acquisition of state-of-the the art equipment (EchoMRI, BIODAQ, metabolic cages and Ussing chambers) during the last granting period. These AMC services are essential not only for the success of the CURE:DDRCC members who are federally funded and anticipate to use the Core (33 members), but are also critical to spur new projects, including the 5 newly federally funded grants on energy metabolism that made use of the new Core equipment and expertise..

Public Health Relevance

The Animal Model Core plays a fundamental role to advance knowledge on several diseases including irritable bowel syndrome, inflammatory bowel diseases, constipation association with neurodegenerative disease and the interaction between the gut and the brain as it relates to food intake and metabolism. The unraveling of new mechanisms and testing new intervention using preclinical models will help to understand these disorders and advance therapeutic venues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK041301-30
Application #
9605771
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
30
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Park, S H; Naliboff, B D; Shih, W et al. (2018) Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 30:
Dong, Tien; Pisegna, Joseph (2018) Passing the ""Acid Test"": Do Proton Pump Inhibitors Affect the Composition of the Microbiome? Dig Dis Sci :
Basheer, Wassim A; Fu, Ying; Shimura, Daisuke et al. (2018) Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia/reperfusion injury. JCI Insight 3:
Jacobs, Jonathan P; Dong, Tien S; Agopian, Vatche et al. (2018) Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatol Res :
Sala-Rabanal, Monica; Ghezzi, Chiara; Hirayama, Bruce A et al. (2018) Intestinal absorption of glucose in mice as determined by positron emission tomography. J Physiol 596:2473-2489
Lin, De-Chen; Dinh, Huy Q; Xie, Jian-Jun et al. (2018) Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas. Gut 67:1769-1779
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Bhattarai, Yogesh; Williams, Brianna B; Battaglioli, Eric J et al. (2018) Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion. Cell Host Microbe 23:775-785.e5
Osadchiy, Vadim; Labus, Jennifer S; Gupta, Arpana et al. (2018) Correlation of tryptophan metabolites with connectivity of extended central reward network in healthy subjects. PLoS One 13:e0201772
May, Folasade P; Yu, Christine; Kaunitz, Jonathan (2018) High quality of cancer care in the Department of Veterans Affairs (VA). Am J Cancer Res 8:761-762

Showing the most recent 10 out of 1097 publications